Beta-blocker use linked to improved ovarian cancer survival. More trials needed to understand results.
Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter retrospective … Continue reading
Women born with mutations in the genes BRCA1 or BRCA2 have an increased risk of developing breast and ovarian cancer. But not all mutations within these genes raise the risk … Continue reading
BC Cancer Agency and UBC Sexual Health Laboratory are seeking participants for a research study of an online support group for women diagnosed with gynecologic cancer.
This Canadian Institute for Health Research (CIHR)-funded study seeks to better understand how cancer survivors access and experience cancer survivorship care systems and resources.
Frontline Medical News interviewed medical oncologist Dr. Peter Harper (London) about our current knowledge of targeted treatments for patients with ovarian cancer.
With support from Ovarian Cancer Canada, researchers at Guelph are focusing on a potential breakthrough against ovarian cancer.
The success of immunotherapy for some cancer patients was highlighted this month in The Globe and Mail.
‘A new biomarker predicts PARP response in ovarian cancer’ was released by MedScape today.
Ovarian Cancer and Endometriosis: Is there a connection?